SCHEMBL2014944

SCHEMBL2014944

CC(Cl)(Oc1ccccc1Cl)C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.43
MAPT P10636 2/20 0.43
KDM4E B2RXH2 1/20 0.42
HSD17B10 Q99714 1/20 0.42
CXCL8 P10145 1/20 0.42
PPARA Q07869 3/20 0.42
PPARG P37231 2/20 0.42
PPARD Q03181 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.41
HSD11B1 P28845 2/20 0.41
HSD11B2 P80365 2/20 0.41
CNR1 P21554 1/20 0.41
HPGD P15428 2/20 0.41
RXRA P19793 1/20 0.41
RXRB P28702 1/20 0.41
TP53 P04637 1/20 0.41
HTT P42858 1/20 0.41
KMT2A Q03164 4/20 0.40
LMNA P02545 1/20 0.40
MEN1 O00255 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1046455 0.84 ALDH1A1 (0.60) ALDH1A1MAPTKDM4EHSD17B10CXCL8
SCHEMBL29195871 0.82 ALDH1A1 (0.58) ALDH1A1MAPTKDM4EHSD17B10CXCL8
SCHEMBL1134749 0.77 PPARA (0.48) ALDH1A1MAPTKDM4EHSD17B10PPARA
SCHEMBL670028 0.77 PPARG (0.39) ALDH1A1MAPTKDM4EHSD17B10CXCL8
SCHEMBL23519085 0.76 CXCL8 (0.44) ALDH1A1MAPTCXCL8PPARAPPARG
SCHEMBL12301773 0.76 HSD11B1 (0.44) ALDH1A1MAPTKDM4EHSD17B10CXCL8
SCHEMBL9589205 0.76 HSD11B1 (0.47) ALDH1A1MAPTKDM4EHSD17B10CXCL8
SCHEMBL2737124 0.76 LMNA (0.43) ALDH1A1MAPTL3MBTL1HPGDHTT
SCHEMBL4247858 0.75 HSD11B1 (0.44) ALDH1A1MAPTKDM4EHSD17B10CXCL8
SCHEMBL3955803 0.74 ALDH1A1 (0.42) ALDH1A1MAPTCXCL8HSD11B1HSD11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2970504-A1 NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF Sage Therapeutics, Inc. (US) 2016-01-20 EP disclosed
EP-2958895-A1 THERAPEUTIC COMPOUNDS AND USES THEREOF Kala Pharmaceuticals, Inc. (US) 2015-12-30 EP disclosed
EP-2303888-B1 COMPOUNDS FOR ANTIMICROBIAL INTERVENTION HARVARD COLLEGE (US) 2015-05-06 EP disclosed
EP-2831079-A1 BICYCLIC HETEROCYCLIC DERIVATIVES AS MNK1 AND MNK2 MODULATORS AND USES THEREOF Agency For Science, Technology And Research (SG) 2015-02-04 EP disclosed
WO-2014160441-A1 NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF SAGE THERAPEUTICS, INC. (US) 2014-10-02 WO disclosed
WO-2014130612-A1 THERAPEUTIC COMPOUNDS AND USES THEREOF KALA PHARMACEUTICALS, INC. (US) 2014-08-28 WO disclosed
WO-2013147711-A1 BICYCLIC HETEROCYCLIC DERIVATIVES AS MNK1 AND MNK2 MODULATORS AND USES THEREOF AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2013-10-03 WO disclosed
EP-2512386-A1 A GASTROINTESTINAL IMPLANT DEVICE Vysera Biomedical Limited (IE) 2012-10-24 EP disclosed
WO-2011073970-A1 A GASTROINTESTINAL IMPLANT DEVICE VYSERA BIOMEDICAL LIMITED (IE) 2011-06-23 WO disclosed
US-6395745-B1 STABLE, CRYSTAL STRUCTURE; PLANT EXTRACT GLYCODESIGN, INC. (CA) 2002-05-28 US disclosed